College of Science and Engineering, Hamad Bin Khalifa University, Doha, Qatar.
Department of Petroleum Engineering, Texas A&M University, Doha, Qatar.
Stud Health Technol Inform. 2022 Jun 29;295:366-369. doi: 10.3233/SHTI220740.
In this study, we addressed the alternative medications that have been targeted in the clinical trials (CTs) to be evidenced as an adjuvant treatment against COVID-19. Based on the outcomes from CTs, we found that dietary supplements such as Lactoferrin, and Probiotics (as SivoMixx) can play a role enhancing the immunity thus can be used as prophylactics against COVID-19 infection. Vitamin D was proven as an effective adjuvant treatment against COVID-19, while Vitamin C role is uncertain and needs more investigation. Herbals such as Guduchi Ghan Vati can be used as prophylactic, while Resveratrol can be used to reduce the hospitalization risk of COVID-19 patients. On the contrary, there were no clinical improvements demonstrated when using Cannabidiol. This study is a part of a two-phase research study. In the first phase, we gathered evidence-based information on alternative therapeutics for COVID-19 that are under CT. In the second phase, we plan to build a mobile health application that will provide evidence based alternative therapy information to health consumers.
在这项研究中，我们针对临床试验（CT）中针对的替代药物进行了研究，以证明其作为 COVID-19 辅助治疗的功效。根据 CT 的结果，我们发现膳食补充剂，如乳铁蛋白和益生菌（如 SivoMixx）可以增强免疫力，因此可以用作 COVID-19 感染的预防措施。维生素 D 已被证明是 COVID-19 的有效辅助治疗方法，而维生素 C 的作用尚不确定，需要进一步研究。草药如 Guduchi Ghan Vati 可用于预防，而白藜芦醇可用于降低 COVID-19 患者的住院风险。相反，使用大麻二酚并未显示出临床改善。本研究是一项两阶段研究的一部分。在第一阶段，我们收集了 CT 中针对 COVID-19 的替代疗法的循证信息。在第二阶段，我们计划构建一个移动健康应用程序，为健康消费者提供基于证据的替代治疗信息。
